Abstract
IL-2 deficiency and associated regulatory T cell (Treg) defects contribute essentially to SLE pathogenesis. In our previous translational work we proved the efficacy and safety of a low-dose IL-2 therapy...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have